Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 05, 2021

SELL
$5.03 - $8.8 $10,874 - $19,025
-2,162 Closed
0 $0
Q3 2020

Oct 27, 2020

BUY
$3.64 - $7.76 $5,776 - $12,315
1,587 Added 276.0%
2,162 $9,000
Q2 2020

Jul 16, 2020

BUY
$4.78 - $8.26 $2,743 - $4,741
574 Added 57400.0%
575 $4,000
Q1 2020

May 20, 2020

SELL
$4.0 - $21.53 $236 - $1,270
-59 Reduced 98.33%
1 $0
Q3 2019

Oct 15, 2019

BUY
$13.89 - $23.16 $13 - $23
1 Added 1.69%
60 $1,000
Q4 2018

Feb 14, 2019

BUY
$12.41 - $22.98 $732 - $1,355
59 New
59 $1,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $218M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Bay Harbor Wealth Management, LLC Portfolio

Follow Bay Harbor Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Harbor Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bay Harbor Wealth Management, LLC with notifications on news.